Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06965426 · ClinicalTrials.gov registry record · NA
Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study
A NA study of Macular Degenerative Disease, sponsored by Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06965426 is a NA study of Macular Degenerative Disease that is actively recruiting participants, run by Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06965426, a NA study of Macular Degenerative Disease, is actively recruiting participants, sponsored by Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare skin carotenoid scores over 12 weeks of individuals randomized to placebo or MacuHealth and comparing that to a 12 week crossover evaluation.
Conditions Studied
Interventions
- OTHER Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
Study Locations (1)
Missouri
- Vision Source - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06965426
The ClinicalTrials.gov registry entry for NCT06965426 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Macular Degenerative Disease appearing as the primary indexed condition, and to 1 intervention - of which Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation is the first listed.
NCT06965426 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT06965426 about?
NCT06965426 is a clinical study titled "Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study". To compare skin carotenoid scores over 12 weeks of individuals randomized to placebo or MacuHealth and comparing that to a 12 week crossover evaluation.
What is the current status of trial NCT06965426?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-06-01. Estimated completion is 2026-12-01.
What conditions does trial NCT06965426 study?
This clinical trial studies the following conditions: Macular Degenerative Disease.
What interventions are being tested in trial NCT06965426?
The interventions under investigation include: Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation (OTHER).
Who is sponsoring clinical trial NCT06965426?
This trial is sponsored by Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06965426 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.